The North America Diabetic Footwear Market would witness market growth of 7.3% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 54,539.3 thousand Units, showcasing a growth of 7.3% (2019-2022).
Traditional stereotypes associated with medical footwear are evolving. Manufacturers increasingly incorporate stylish designs into diabetic footwear, challenging the perception that comfort and fashion are mutually exclusive. This shift is crucial in promoting the regular use of diabetic footwear, as individuals are more likely to wear shoes that align with their style. Advancements in materials and technology have paved the way for innovative features in diabetic footwear. Smart insoles, pressure sensors, and temperature-regulating materials are integrated into these shoes, providing users real-time data about their foot health. This enhances the user experience and contributes to proactive foot care.
Brands increasingly incorporate sustainable practices into their production, resonating with environmentally conscious consumers. Recognizing the diverse needs of individuals, some manufacturers offer customization services for diabetic footwear. This includes personalized sizing, orthotic inserts, and design choices, ensuring users receive footwear tailored to their unique foot characteristics and preferences. Collaborations between diabetic footwear manufacturers and healthcare institutions or professionals are rising. This enhances the credibility of the products and ensures that the footwear meets the specific needs of individuals with diabetes. Such partnerships contribute to ongoing research and development in the field.
As per the data provided by the Centers for Disease Control and Prevention of the United States, in 2021, 29.7 million people of all ages—or 8.9% of the US population—had been diagnosed with diabetes. 352,000 children and adolescents younger than age 20 years—or 35 per 10,000 US youths—had been diagnosed with diabetes. 5.7% of all adults in the United States with diagnosed diabetes, or 1.7 million adults aged 20 years or older, reported having type 1 diabetes. Therefore, rising diabetes cases in many nations of North America is expected to boost the demand for diabetic footwear in the region.
The US market dominated the North America Diabetic Footwear Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,493.4 Million by 2030. The Canada market is showcasing a CAGR of 9.7% during (2023 - 2030). Additionally, The Mexico market would register a CAGR of 8.8% during (2023 - 2030).
Based on End User, the market is segmented into Women and Men. Based on Type, the market is segmented into Shoes, Sandals and Slippers. Based on Distribution Channel, the market is segmented into Specialty Stores, Online Platform, Footwear Stores and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Diabetic Footwear Market is Predict to reach $13 Billion by 2030, at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.
By End User (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Distribution Channel (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Country (Volume, Thousand Units, USD Billion/Million, 2019-2030)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 